Deciphering the role of insulin-like growth factor-I receptor in trastuzumab resistance.

Chemother Res Pract · 2012 · PMC3399380 · PMID 22830017

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Tumor growth of MCF7/HER2 xenografts was not inhibited by single-agent trastuzumab, whereas single-agent IGFBP3 showed a trend toward growth inhibition [ 16 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.